594 related articles for article (PubMed ID: 33528830)
1. Current approaches in lipid-based nanocarriers for oral drug delivery.
Plaza-Oliver M; Santander-Ortega MJ; Lozano MV
Drug Deliv Transl Res; 2021 Apr; 11(2):471-497. PubMed ID: 33528830
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
3. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Suchaoin W; Bernkop-Schnürch A
Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
[TBL] [Abstract][Full Text] [Related]
5. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
Nabi B; Rehman S; Baboota S; Ali J
AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
[TBL] [Abstract][Full Text] [Related]
6. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
8. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review.
Gunawan M; Boonkanokwong V
Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
Okur NÜ; Siafaka PI; Gökçe EH
Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
[TBL] [Abstract][Full Text] [Related]
10. Structured edible lipid-based particle systems for oral drug-delivery.
Ashkar A; Sosnik A; Davidovich-Pinhas M
Biotechnol Adv; 2022; 54():107789. PubMed ID: 34186162
[TBL] [Abstract][Full Text] [Related]
11. Surface design of nanocarriers: Key to more efficient oral drug delivery systems.
Spleis H; Sandmeier M; Claus V; Bernkop-Schnürch A
Adv Colloid Interface Sci; 2023 Mar; 313():102848. PubMed ID: 36780780
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
Silva AC; Santos D; Ferreira D; Lopes CM
Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
[TBL] [Abstract][Full Text] [Related]
14. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
Karamanidou T; Bourganis V; Kammona O; Kiparissides C
Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
[TBL] [Abstract][Full Text] [Related]
15. Lipid-Based Nanocarriers for Lymphatic Transportation.
Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Functionalized Polymeric Nanoparticles to Improve Intestinal Permeability of Drugs and Biological Products.
de Souza ML; de Albuquerque Wanderley Sales V; Alves LP; Dos Santos WM; de Moura Ferraz LR; de Andrade Lima GS; Dos Santos Mendes LM; Rolim LA; Neto PJR
Curr Pharm Des; 2022; 28(5):410-426. PubMed ID: 34348618
[TBL] [Abstract][Full Text] [Related]
17. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
18. Lipid-based nanocarriers for oral peptide delivery.
Niu Z; Conejos-Sánchez I; Griffin BT; O'Driscoll CM; Alonso MJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):337-354. PubMed ID: 27080735
[TBL] [Abstract][Full Text] [Related]
19. Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery.
Wu L; Liu M; Zhu X; Shan W; Huang Y
Curr Pharm Des; 2015; 21(36):5198-211. PubMed ID: 26412355
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles for enhanced oral absorption: A review.
Salah E; Abouelfetouh MM; Pan Y; Chen D; Xie S
Colloids Surf B Biointerfaces; 2020 Dec; 196():111305. PubMed ID: 32795844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
